Cargando…
TOPBP1 missense variant Arg309Cys and breast cancer in a German hospital-based case-control study
The DNA double strand break repair gene TOPBP1 has been suggested as a breast cancer susceptibility gene and a missense variant Arg309Cys was observed at elevated frequency in familial breast cancer cases compared to healthy controls from Finland. We found the Arg309Cys allele at a 13% carrier frequ...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002300/ https://www.ncbi.nlm.nih.gov/pubmed/21108795 http://dx.doi.org/10.1186/1477-5751-9-9 |
_version_ | 1782193725583130624 |
---|---|
author | Blaut, Magda A Bogdanova, Natalia V Bremer, Michael Karstens, Johann H Hillemanns, Peter Dörk, Thilo |
author_facet | Blaut, Magda A Bogdanova, Natalia V Bremer, Michael Karstens, Johann H Hillemanns, Peter Dörk, Thilo |
author_sort | Blaut, Magda A |
collection | PubMed |
description | The DNA double strand break repair gene TOPBP1 has been suggested as a breast cancer susceptibility gene and a missense variant Arg309Cys was observed at elevated frequency in familial breast cancer cases compared to healthy controls from Finland. We found the Arg309Cys allele at a 13% carrier frequency in a hospital-based series of 1064 German breast cancer patients and at a 14% carrier frequency in 1014 population controls (OR 0.89, 95%CI 0.69-1.15; p = 0.4). Arg309Cys carriers were not enriched among patients with a family history of breast cancer (OR = 0.87, 95%CI 0.53-1.43, p = 0.6) and were slightly underrepresented in patients with bilateral disease (OR = 0.49, 95%CI = 0.24-0.99; p = 0.047). In the latter group, the mean age at diagnosis was 62 years in carriers and 54 years in non-carriers (p = 0.004). We conclude that there is no evidence for the TOPBP1*Arg309Cys variant to confer an increased risk for breast cancer in the German population. |
format | Text |
id | pubmed-3002300 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30023002010-12-16 TOPBP1 missense variant Arg309Cys and breast cancer in a German hospital-based case-control study Blaut, Magda A Bogdanova, Natalia V Bremer, Michael Karstens, Johann H Hillemanns, Peter Dörk, Thilo J Negat Results Biomed Brief Report The DNA double strand break repair gene TOPBP1 has been suggested as a breast cancer susceptibility gene and a missense variant Arg309Cys was observed at elevated frequency in familial breast cancer cases compared to healthy controls from Finland. We found the Arg309Cys allele at a 13% carrier frequency in a hospital-based series of 1064 German breast cancer patients and at a 14% carrier frequency in 1014 population controls (OR 0.89, 95%CI 0.69-1.15; p = 0.4). Arg309Cys carriers were not enriched among patients with a family history of breast cancer (OR = 0.87, 95%CI 0.53-1.43, p = 0.6) and were slightly underrepresented in patients with bilateral disease (OR = 0.49, 95%CI = 0.24-0.99; p = 0.047). In the latter group, the mean age at diagnosis was 62 years in carriers and 54 years in non-carriers (p = 0.004). We conclude that there is no evidence for the TOPBP1*Arg309Cys variant to confer an increased risk for breast cancer in the German population. BioMed Central 2010-11-25 /pmc/articles/PMC3002300/ /pubmed/21108795 http://dx.doi.org/10.1186/1477-5751-9-9 Text en Copyright ©2010 Blaut et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Report Blaut, Magda A Bogdanova, Natalia V Bremer, Michael Karstens, Johann H Hillemanns, Peter Dörk, Thilo TOPBP1 missense variant Arg309Cys and breast cancer in a German hospital-based case-control study |
title | TOPBP1 missense variant Arg309Cys and breast cancer in a German hospital-based case-control study |
title_full | TOPBP1 missense variant Arg309Cys and breast cancer in a German hospital-based case-control study |
title_fullStr | TOPBP1 missense variant Arg309Cys and breast cancer in a German hospital-based case-control study |
title_full_unstemmed | TOPBP1 missense variant Arg309Cys and breast cancer in a German hospital-based case-control study |
title_short | TOPBP1 missense variant Arg309Cys and breast cancer in a German hospital-based case-control study |
title_sort | topbp1 missense variant arg309cys and breast cancer in a german hospital-based case-control study |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002300/ https://www.ncbi.nlm.nih.gov/pubmed/21108795 http://dx.doi.org/10.1186/1477-5751-9-9 |
work_keys_str_mv | AT blautmagdaa topbp1missensevariantarg309cysandbreastcancerinagermanhospitalbasedcasecontrolstudy AT bogdanovanataliav topbp1missensevariantarg309cysandbreastcancerinagermanhospitalbasedcasecontrolstudy AT bremermichael topbp1missensevariantarg309cysandbreastcancerinagermanhospitalbasedcasecontrolstudy AT karstensjohannh topbp1missensevariantarg309cysandbreastcancerinagermanhospitalbasedcasecontrolstudy AT hillemannspeter topbp1missensevariantarg309cysandbreastcancerinagermanhospitalbasedcasecontrolstudy AT dorkthilo topbp1missensevariantarg309cysandbreastcancerinagermanhospitalbasedcasecontrolstudy |